Center for Biologics Evaluation and Research, FDA Site Visit Introduction Michael J. Brennan, Ph.D. for Kathryn M. Carbone, M.D. Associate Director for.
FDA’s Critical Path Research Initiative & Intro to the CBER Research Program
